Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Prevention of Tunneled Hemodialysis Catheter Dysfunction
NCT07404345Phase 4Not yet recruiting
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in hemodialysis vascular access failure, sponsored by Hospital Civil de Guadalajara. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
hemodialysis vascular access failure
Beyond the preview
Go deeper on NCT07404345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07404345.